FFO
KLRA

Fortitude Family Office’s Kailera Therapeutics KLRA Stock Holding History

Fortitude Family Office’s Portfolio KLRA Stock Details KLRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$705 Buy
+32
New +$703 ﹤0.01% 1879

Other funds holding KLRA

ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $549M AUM 54.99% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Fortitude Family Office's KLRA Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Kailera Therapeutics (KLRA) in Q2 2026: 32 shares worth $705. The stake represents ﹤0.01% of the portfolio and ranks #1879 among its holdings.

6 funds tracked by Wall St. Rank hold KLRA as of Q2 2026.

  • Fortitude Family Office held 32 shares of Kailera Therapeutics worth $705 as of Q2 2026.
  • Kailera Therapeutics was a new Fortitude Family Office position in Q2 2026.
  • Kailera Therapeutics made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1879 holding.
  • 6 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.